Spirofuropyridine aryl derivatives

Details for Australian Patent Application No. 2004285751 (hide)

Owner AstraZeneca AB

Inventors Phillips, Eifion

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004285751

PCT Pub. Number WO2005/042538

Priority 60/512,893 21.10.03 US

Filing date 21 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 24 July 2008

International Classifications

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/042538 Priority application(s): WO2005/042538

24 July 2008 Application Accepted

  Published as AU-B-2004285751

20 November 2008 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285752-Thieno-pyridinone derivatives as kinase inhibitors

2004285750-Process for the manufacture of the calcium salt of rosuvatatin (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[ methyl(methylsulfonyl) amino]pyrimidin-5-yl](3R, 5S)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof